Alcon announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency supports the safety and efficacy of brinzolamide eye drops suspension for adult patients with open-angle glaucoma or ocular hypertension, according…
Viewpoints: It’s past time to move on VA’s problems; administration should report new health law numbers
When America sends men and women to fight, it owes them an enduring debt, starting with competent and timely health care and disability benefits when they leave active duty. President Obama expressed outrage on Wednesday at recent charges of wrongdoing…
CDVA lost in short-term, regained at 1 year after SMILE
Small-incision lenticule extraction showed an acceptable safety profile despite a relatively high percentage of eyes that lost corrected distance visual acuity at 3 months, according to a study.The clinical-control cohort study included 1,800 eyes of 9…
Novartis reports 2014 Q1 sales, profit growth
Novartis reported a 1% increase in net sales to $14 billion in the first quarter of 2014, according to a press release.“Novartis delivered a solid quarter, with all divisions contributing to growth. We made progress in innovation, including [European Union] and U.S. approval of Xolair in chronic spontaneous urticaria and significant milestones for Bexsero,” Joseph Jimenez, CEO of Novartis, said in the release.
Regeneron announces $626 million in 2014 first quarter revenue
Regeneron reported total revenue of $626 million in the first quarter of 2014, a 42% increase from its 2013 first quarter revenue of $440 million, according to a press release.Net product sales were reported at $362 million, increasing by $43 million f…
Surgical Innovations in Pediatric Ophthalmology
iTunes conversion to RSS provided by Feed Flipper: [Web] – [Facebook] – [Donate!]
Dr. Stefanie Davidson reviews the highlights from this year’s American Association for Pediatric Ophthalmology and Strabismus (AAPOS) meeting.